Thanks you Kes Grant 🇪🇺. We need and value the insights, experience and critique that patients bring when we are designing research proposals. We need to get better at involving patients right from the start to make our questions relevant@act4patients Charlie Craddock CBE Paul Sherrington

Outstanding intro by ⁦Pramila Krishnamurthy⁩ to 2nd DIDACT Academy. Important opening discussions on PPI and with ⁦Paul Sherrington⁩ how best to work with pharma. Looking forward to Dragons Den, mentoring review and ⁦Accelerating Clinical Trials⁩ update. Thank you ⁦Leukaemia UK⁩!

Massive congratulations to my brilliant colleague Sridhar Chaganti and UK colleagues for delivery of this pivotal trial. Brilliant academic leadership and great collaboration within UK lymphoma network.

Thank you for your brilliant talk Rakesh Popat. It’s been a fantastic #EBMT24 and the organising committee is delighted that an emphasis on equity aswell as new inclusive discussion formats such as the EBMT Contest has proved so popular. Onward! vp Anne Parker

Charlie Craddock CBE talking at The EBMT and Anthony Nolan session at #EBMT24 demonstrating how important registries are for transplants and how need to go hand in hand with research.

Career advice from the dynamic duo Drs. Dr. Julie Brahmer & Natasha Leighl
#lcsm

Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for #AML #leusm |British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/full/10.11…

Thank you Cure Leukaemia for your unwavering support to TAP trial network and future trial delivery models Accelerating Clinical Trials Thank you Andy Street for visiting Centre for Clinical Haematology.

Outstanding turnout for London meeting of UK Trials Acceleration Programme network funded by Accelerating Clinical Trials. Tremendous clinical leadership from Chris Fox Pramila Krishnamurthy and Steve Knapper. Thanks as always to our inspired funders Cure Leukaemia

A great privilege to debate with THE REAL MRD EXPERT Chris Hourigan how to optimally deliver transplant in AML patients with evidence of MRD. We agreed on much especially the importance of randomised trials to answer this question Accelerating Clinical Trials Cure Leukaemia Anthony Nolan

#ESHAL2024 Jordi Esteve chairs a very entertaining - and not entirely serious - debate discussing whether AML MRD conversion before alloSCT has to be achieved. Chris Hourigan is PRO; Charlie Craddock CBE is CON: Stay tuned, debate soon available on #ESHELEARNING
#ESHCONFERENCES

In the last six months we have been working hard to create a collaborative and efficient environment for vaccine trials. This is crucial for addressing global health challenges effectively. nihr.ac.uk/blog/how-the-v…

Calling all Flutter plc employees, Cure Leukaemia needs your vote and you have just one day left!

We are one of the 5 charities shortlisted to be the official charity partner of the year for Flutter UK&I in 2024

YOUR vote WILL help save children's lives across UK & Ireland!…

Calling all Flutter plc employees, Cure Leukaemia needs your vote!

We are one of the 5 charities shortlisted to be the official charity partner of the year for Flutter UK&I in 2024

YOUR vote WILL help save children's lives across UK & Ireland!

The funds raised by being your…

Remarkable leadership of this transformative blood cancer charity. Henny always puts patients first as she champions innovative models of transplant and clinical trial delivery.

Exciting to see Accelerating Clinical Trials cited as a model of innovative clinical trial delivery in the pivotal Office for Life Sciences commissioned O’Shaughnessy Report. Growing recognition internationally that accelerated trial delivery is now vital to improve patient outcomes. James O'Shaughnessy

Explore the exciting lineup of Hematology Oncology events scheduled for this year! We are delighted to share our esteemed co-chairs for these meetings. Browse through the dates, find the sessions that pique your interest, and mark your calendar! 📆 With great agendas covering…

We’re hosting a Post-ASH Virtual Highlights Series, featuring presentations & discussions on selected abstracts from #ASH23 , with leading #HemOnc experts 💻🩸

Join us for our #AML session chaired by Naval Daver, M.D.

Check out the agenda & REGISTER NOW 👉 vjhemonc.com/feature/post-a…

Brilliant news. Innovative patient centred blood cancer charities working cohesively to fund a trials infrastructure essential to improve transplant outcomes. Congratulations Anthony Nolan Cure Leukaemia NHS Blood+Transplant for your vision and commitment to patients